Jun 24, 2021

Dr. Philip Felgner of UCI’s VRDC wins Spain’s prestigious Princess of Asturias award for scientific research

January 20, 2021

In the COVID-19 Press:

UC Irvine researchers launch COVID-19 antibody study in Santa Ana

Finding OC’s true COVID-19 rates

Estimated Seroprevalence of SARS-CoV-2 Antibodies Among Adults in Orange County, California (medRxiv preprint)

April 18, 2020

Our lab’s latest SARS-CoV-2 BioRxiv preprints

Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses
and SARS-CoV-2 Using Coronavirus Antigen Microarray

Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a
Coronavirus Antigen Microarray

April 18, 2020

In the COVID-19 Press: Doctors race to develop coronavirus drugs, speeding through hurdles

Sino Biological Partners with Nanommune Inc. to Develop and Market a Novel Coronavirus Multiplex Serological Assay

Could a blood test for coronavirus antibodies get California back to normal? Lots of questions remain

Where California stands with coronavirus testing right now

DARPA-funded microchip technology optimizes convalescent plasma therapy for COVID-19 patients

March 31, 2020

In the Press: UCI Tech Can Provide Better Understanding of COVID-19 and Vaccine Possibilities

Featured on UCI Beall Applied Innovation’s news blog highlighting our lab’s efforts to further COVID-19 research

March 26, 2020

“The U.S. faces two disastrous scenarios. There’s a third option.”, by the Washington Post.

Also: TWIV Coronavirus Update (3/25/2020), A serological assay to detect SARS-CoV-2 seroconversion in humans

January 26, 2020

“How to protect yourself against the Coronavirus”, an interview with Dr. Peter Hotez of Baylor College on symptoms, treatment, and a vaccine.